PHIO Phio Pharmaceuticals
- 1.8400
- -0.1300-6.60%
- 1.9000
- +0.0600+3.26%
Phio Pharmaceuticals News
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | SCHEDULE 13G: Others
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | SCHEDULE 13G: Others
Phio Pharmaceuticals | 424B5: Prospectus
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 424B5: Prospectus
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Phio Pharmaceuticals | 8-K: Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Phio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Infarinato Robert M.
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Freeman Jonathan E
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BRADFORD PATRICIA A
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ferrara Robert L
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lockshin Curtis
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Infarinato Robert M.
Phio Pharmaceuticals | 8-K: Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
No Data